Binding of 5-methoxypsoralen to human serum low density lipoproteins.
5-methoxypsoralen (5-MOP) binds to human serum low density lipoproteins (LDL) according to a two-step process. Scatchard analysis of the first step yields K = 1.4 X 10(5) M-1 and 4 binding sites. It involves the LDL apoprotein. The second step corresponds to a solubilization, in the lipidic core, of congruent to 45 molecules of 5MOP per LDL molecule. It is accompanied by a large blue shift of the 5MOP fluorescence. The ability of LDL to bind 5MOP and to carry it into various cells may explain some biological effects sometimes encountered during PUVA therapy.
D000078223:5-Methoxypsoralen; D001665:Binding Sites; D006801:Humans; D008077:Lipoproteins, LDL / Q000097:blood*; D008730:Methoxsalen / Q000097:blood*; D011485:Protein Binding; D011487:Protein Conformation; D012709:Serum Albumin / Q000378:metabolism; D013050:Spectrometry, Fluorescence
D008077:Lipoproteins, LDL; D012709:Serum Albumin; D000078223:5-Methoxypsoralen; D008730:Methoxsalen